BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
10.75
0.00 (0.00%)
At close: Jun 02, 2025, 2:15 PM
0.00% (1D)
| Bid | 10.7 |
| Market Cap | 2.25B |
| Revenue (ttm) | 503.49M |
| Net Income (ttm) | -53.47M |
| EPS (ttm) | -0.26 |
| PE Ratio (ttm) | -41.34 |
| Forward PE | 27.86 |
| Analyst | Buy |
| Ask | 10.79 |
| Volume | 2,323,146 |
| Avg. Volume (20D) | 4,619,192 |
| Open | 10.79 |
| Previous Close | 10.75 |
| Day's Range | 10.74 - 11.15 |
| 52-Week Range | 5.92 - 11.15 |
| Beta | 1.07 |
About BCRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 weeks ago
+23.52%
BioCryst Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
3 months ago
-9.99%
BioCryst Pharmaceuticals shares are trading lower after the company reported Q4 financial results and missed its adjusted EPS estimate.
4 weeks ago · seekingalpha.com
BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2025 Earnings Call TranscriptBioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX ) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ET Company Participants John Bluth - Chief Communications Officer Jon Stonehouse - CEO Charlie Gayer ...
